A recently published study has compared a new surgical method with the current standard treatment for primary management of cervical cancer.
The new method, called cancer field surgery (Total Mesometrial Resection, TMMR), was developed over 20 years ago by our partners at the . Previous publications have suggested favorable results without the need for radiation therapy. Omitting radiation therapy could potentially improve quality of life for treated women.
In the study, we demonstrate that TMMR is associated with improved oncological outcomes for early stages of cervical cancer. Our data suggest that TMMR may replace current treatment strategies and radiation therapy could be spared for salvage treatment. This breakthrough motivates continued work in this field.
Research of this kind heavily relies on well-functioning collaborations with other researchers. Beyond providing essential data for the project, it also strengthens international cooperation, facilitating the dissemination of our findings. We plan to further explore the potential of cancer field surgery in gynecological cancer to establish the method in future treatment strategies.